Post-IPO Equity - Obalon Therapeutics
Investment Firm
Overview
Obalon Therapeutics offers gastric balloon technology that assists weight loss.
Announced Date
Aug 27, 2018
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Obalon Therapeutics raised $10000000 on 2018-08-27 in Post-IPO Equity
Obalon Therapeutics offers gastric balloon technology that assists weight loss.
Company Funding History
13
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 02, 2014 |  Venture Round - Obalon Therapeutics | - | 15.9M | |
| Mar 26, 2012 | Debt Financing - Obalon Therapeutics | - | 1.5M | |
| Dec 19, 2012 | Venture Round - Obalon Therapeutics | 1 | - | 5.0M |
| Jul 18, 2012 | Series C - Obalon Therapeutics | 3 | - | 16.5M |
Recent Activity
There is no recent news or activity for this profile.